hexamethylene bisacetamide has been researched along with Carcinoma, Embryonal in 7 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)
Excerpt | Relevance | Reference |
---|---|---|
"Upon HMBA treatment, the embryonal carcinoma cell line NTERA-2 clone D1 (NT2/D1) accumulates in G1 and undergoes terminal differentiation." | 1.30 | Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. ( Baldassarre, G; Barone, MV; Belletti, B; Boccia, A; Bruni, P; Fusco, A; Pepe, S; Romano, A; Sandomenico, C; Spiezia, S; Vento, MT; Viglietto, G, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayman, MW | 1 |
Christie, VB | 1 |
Keating, TS | 1 |
Przyborski, SA | 1 |
Andrews, PW | 2 |
Damjanov, I | 1 |
Berends, J | 1 |
Kumpf, S | 1 |
Zappavigna, V | 1 |
Mavilio, F | 1 |
Sampath, K | 1 |
Nakamura, T | 1 |
Okuyama, S | 2 |
Okamoto, S | 2 |
Nakajima, T | 2 |
Sekiya, S | 2 |
Oda, K | 2 |
Moasser, MM | 1 |
Khoo, KS | 1 |
Maerz, WJ | 1 |
Zelenetz, A | 1 |
Dmitrovsky, E | 1 |
Wakeman, JA | 1 |
Walsh, J | 1 |
Suzuki, M | 1 |
Shirasuna, K | 1 |
Hachiya, T | 1 |
Nojima, H | 1 |
Baldassarre, G | 1 |
Barone, MV | 1 |
Belletti, B | 1 |
Sandomenico, C | 1 |
Bruni, P | 1 |
Spiezia, S | 1 |
Boccia, A | 1 |
Vento, MT | 1 |
Romano, A | 1 |
Pepe, S | 1 |
Fusco, A | 1 |
Viglietto, G | 1 |
7 other studies available for hexamethylene bisacetamide and Carcinoma, Embryonal
Article | Year |
---|---|
Following the differentiation of human pluripotent stem cells by proteomic identification of biomarkers.
Topics: Acetamides; Antigens, Surface; Antigens, Tumor-Associated, Carbohydrate; Biomarkers; Carcinoma, Embr | 2006 |
Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Topics: Acetamides; Antineoplastic Agents; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Carcin | 1994 |
Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.
Topics: Acetamides; Activating Transcription Factor 2; Activating Transcription Factors; Base Sequence; Bloo | 1995 |
Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Topics: Acetamides; Animals; Antineoplastic Agents; Base Sequence; Carcinoma, Embryonal; Cell Differentiatio | 1996 |
Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Topics: Acetamides; Base Sequence; Carcinoma, Embryonal; Cell Differentiation; Drosophila Proteins; Frizzled | 1998 |
A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
Topics: Acetamides; Amino Acid Sequence; Base Sequence; Carcinoma, Embryonal; Carrier Proteins; Cell Cycle P | 1998 |
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
Topics: Acetamides; Antigens, Neoplasm; Antigens, Surface; Antigens, Tumor-Associated, Carbohydrate; Apoptos | 1999 |